Edwards Lifesciences Cost of Revenue Trend |
| Edwards Lifesciences Corporation -- USA Stock | USD 137.09 1.47 1.06% |
This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Cost of Revenue of Edwards Lifesciences Corporation with missing and latest data points interpolated. Cost of Revenue is found on Edwards Lifesciences income statement and represents the costs associated with goods and services Edwards Lifesciences provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. The aggregate cost of goods produced and sold and services rendered during the reporting period.
| Cost of Revenue | 10 Years Trend |
| Compare to Other EquitiesAll Fundamental Data |
Regression Statistics
| Arithmetic Mean | 539,109,717 |
| Geometric Mean | 517,329,178 |
| Coefficient Of Variation | 30.18 |
| Mean Deviation | 136,396,574 |
| Median | 491,000,000 |
| Standard Deviation | 162,722,878 |
| Range | 473,700,000 |
| R Value | 0.95 |
| R Squared | 0.91 |
| Significance | 0.00000048 |
| Slope | 39,823,395 |
Edwards Lifesciences Cost of Revenue Over Time
Other Fundumenentals
My Equities
My Current Equities and Potential Positions
| View AllNext |
WEN - USA StockThe Wendys Company |
 | Restaurants Hotels MotelsFama & French Classification |
| Region | North America |
| Exchange | NASDAQ |
$17.15
Thematic Opportunities
Explore Investment Opportunities
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.